A review of exhaled breath: a key role in lung cancer diagnosis
暂无分享,去创建一个
Luca Mainardi | Pietro Cerveri | Davide Marzorati | Giulia Sedda | Roberto Gasparri | Lorenzo Spaggiari | L. Mainardi | P. Cerveri | R. Gasparri | L. Spaggiari | G. Sedda | Davide Marzorati
[1] M S Pepe,et al. Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.
[2] Peter J Sterk,et al. An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.
[3] Madara Tirzïte,et al. Detection of lung cancer with electronic nose and logistic regression analysis , 2018, Journal of breath research.
[4] Andrea Bonarini,et al. Lung Cancer Identification by an Electronic Nose based on an Array of MOS Sensors , 2007, 2007 International Joint Conference on Neural Networks.
[5] D. Huo,et al. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening , 2018, Analytical and Bioanalytical Chemistry.
[6] Werner Lindinger,et al. Proton-transfer-reaction mass spectrometry (PTR–MS): on-line monitoring of volatile organic compounds at pptv levels , 1998 .
[7] T. Walles,et al. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon , 2011, European Respiratory Journal.
[8] H. Haick,et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. , 2009, Nature nanotechnology.
[9] A. B. Robinson,et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[10] Paolo Montuschi,et al. Analysis of exhaled breath condensate for monitoring airway inflammation. , 2002, Trends in pharmacological sciences.
[11] A. Pomerantz,et al. The possibility of inventing new technologies in the detection of cancer by applying elements of the canine olfactory apparatus. , 2015, Medical hypotheses.
[12] Ildiko Horvath,et al. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer , 2014, BMC Pulmonary Medicine.
[13] Terence H Risby,et al. Effects of ventilation on the collection of exhaled breath in humans. , 2004, Journal of applied physiology.
[14] M. Phillips,et al. Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. , 2000, The Journal of laboratory and clinical medicine.
[15] A. Celzard,et al. Detection and quantification of lung cancer biomarkers by a micro-analytical device using a single metal oxide-based gas sensor , 2018 .
[16] Anton Amann,et al. Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas , 2007 .
[17] David Smith,et al. Time variation of ammonia, acetone, isoprene and ethanol in breath: a quantitative SIFT-MS study over 30 days. , 2003, Physiological measurement.
[18] J. Baumbach. Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath , 2009, Journal of breath research.
[19] M. Mcculloch,et al. Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers , 2006, Integrative cancer therapies.
[20] B. Buszewski,et al. Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. , 2009, Biomedical chromatography : BMC.
[21] Cancer odor in the blood of ovarian cancer patients: a retrospective study of detection by dogs during treatment, 3 and 6 months afterward , 2013, BMC Cancer.
[22] Ulrike Tisch,et al. Classification of lung cancer histology by gold nanoparticle sensors. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[23] Konstantin Nikolic,et al. Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer , 2018, JAMA oncology.
[24] Arash Naeim,et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. , 2014, The New England journal of medicine.
[25] L. Bianchi,et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.
[26] H. Haick,et al. Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules , 2016, ACS nano.
[27] A. Hansel,et al. Acetonitrile and benzene in the breath of smokers and non-smokers investigated by proton transfer reaction mass spectrometry (PTR-MS) , 1995 .
[28] I. Horváth,et al. Exhaled biomarkers in lung cancer , 2009, European Respiratory Journal.
[29] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[30] Dianne B. Walker,et al. Evidence for canine olfactory detection of melanoma , 2004 .
[31] Giorgio Pennazza,et al. An investigation on electronic nose diagnosis of lung cancer. , 2010, Lung cancer.
[32] Krishna C. Persaud,et al. Analysis of volatile organic compounds in exhaled breath for lung cancer diagnosis using a sensor system , 2018 .
[33] Tarek Mekhail,et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array , 2007, Thorax.
[34] B. Buszewski,et al. Identification of volatile lung cancer markers by gas chromatography–mass spectrometry: comparison with discrimination by canines , 2012, Analytical and Bioanalytical Chemistry.
[35] D. Aberle,et al. Results of initial low-dose computed tomographic screening for lung cancer. , 2013, The New England journal of medicine.
[36] A. Dzien,et al. Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants , 2012, Journal of breath research.
[37] T. Walles,et al. Comparison of volatile organic compounds from lung cancer patients and healthy controls—challenges and limitations of an observational study , 2016, Journal of breath research.
[38] Bogusław Buszewski,et al. Application of an artificial neural network model for selection of potential lung cancer biomarkers , 2015, Journal of breath research.
[39] David Smith,et al. Mass spectrometry for real-time quantitative breath analysis , 2014, Journal of breath research.
[40] M. Phillips,et al. Breath tests in medicine. , 1992, Scientific American.
[41] C. Creaser,et al. Detection of volatile organic compounds in breath using thermal desorption electrospray ionization-ion mobility-mass spectrometry. , 2010, Analytical chemistry.
[42] P. Mazzone,et al. Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.
[43] K. Kostikas,et al. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. , 2009, Lung cancer.
[44] B. Tong,et al. Computed tomography screening for lung cancer: where are we now? , 2013, North Carolina medical journal.
[45] David Zhang,et al. A Novel Medical E-Nose Signal Analysis System , 2017, Sensors.
[46] P Rolfe,et al. The selected ion flow tube (SIFT)--a novel technique for biological monitoring. , 1996, The Annals of occupational hygiene.
[47] A. Paradiso,et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. , 2008, American journal of respiratory and critical care medicine.
[48] D. Smith,et al. Selected Ion Flow Tube Mass Spectrometry for On-Line Trace Gas Analysis in Biology and Medicine , 2007, European journal of mass spectrometry.
[49] Wang Li,et al. Lung Cancer Screening Based on Type-different Sensor Arrays , 2017, Scientific Reports.
[50] B. Kremer,et al. Training and Validating a Portable Electronic Nose for Lung Cancer Screening , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[51] B. Buszewski,et al. The application of statistical methods using VOCs to identify patients with lung cancer , 2011, Journal of breath research.
[52] M. Phillips,et al. Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[53] A. Kessels,et al. Application of an electronic nose in the diagnosis of head and neck cancer , 2014, The Laryngoscope.
[54] F. Foret,et al. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review. , 2013, Analytica chimica acta.
[55] E. Martinelli,et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. , 2003, Biosensors & bioelectronics.
[56] Alessandro Borri,et al. Diagnostic biomarkers for lung cancer prevention , 2018, Journal of breath research.
[57] Yixiang Duan,et al. Breath biomarkers in diagnosis of pulmonary diseases. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[58] Jiemin Zhou,et al. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis. , 2017, Analytica chimica acta.
[59] Liang Feng,et al. Colorimetric sensor array for determination and identification of toxic industrial chemicals. , 2010, Analytical chemistry.
[60] C. Willis,et al. Olfactory detection of human bladder cancer by dogs: proof of principle study , 2004, BMJ : British Medical Journal.
[61] Werner Lindinger,et al. Proton transfer reaction mass spectrometry: on-line trace gas analysis at the ppb level , 1995 .
[62] Bogusław Buszewski,et al. Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.
[63] J. Austin,et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[64] Reyer Zwiggelaar,et al. Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls , 2012, Journal of breath research.
[65] Shih-An Yu,et al. A Portable Micro Gas Chromatography System for Lung Cancer Associated Volatile Organic Compound Detection , 2016, IEEE Journal of Solid-State Circuits.
[66] HywelC. Williams,et al. SNIFFER DOGS IN THE MELANOMA CLINIC? , 1989, The Lancet.
[67] L. Freitag,et al. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study , 2009, Thorax.
[68] Dong Xiang,et al. Metal Oxide Gas Sensors: Sensitivity and Influencing Factors , 2010, Sensors.
[69] Š. Matejčík,et al. Corona discharge ion mobility spectrometry with orthogonal acceleration time of flight mass spectrometry for monitoring of volatile organic compounds. , 2012, Analytical chemistry.
[70] David Smith,et al. Quantification of trace levels of the potential cancer biomarkers formaldehyde, acetaldehyde and propanol in breath by SIFT-MS , 2008, Journal of breath research.
[71] R. Paolesse,et al. Metalloporphyrins based artificial olfactory receptors , 2007 .
[72] H. Kuhn,et al. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. , 2004, Lung cancer.
[73] Giorgio Pennazza,et al. Volatile signature for the early diagnosis of lung cancer , 2016, Journal of breath research.
[74] Zvi Boger,et al. Early non-invasive detection of breast cancer using exhaled breath and urine analysis , 2018, Comput. Biol. Medicine.
[75] J. Austin,et al. Prediction of lung cancer using volatile biomarkers in breath. , 2007, Cancer biomarkers : section A of Disease markers.
[76] H. Haick,et al. MA01.01 Detection of Lung Cancer and EGFR Mutations by Electronic Nose System , 2017 .
[77] K. Unterkofler,et al. Breath isoprene – aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study , 2008, Clinical chemistry and laboratory medicine.
[78] W. Miekisch,et al. Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[79] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[80] W. Miekisch,et al. Breath gas aldehydes as biomarkers of lung cancer , 2009, International journal of cancer.
[81] Radu Ionescu,et al. Volatile fingerprints of cancer specific genetic mutations. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[82] Rebecca L. Siegel Mph,et al. Cancer statistics, 2016 , 2016 .
[83] J. Jett,et al. Progress in the development of volatile exhaled breath signatures of lung cancer. , 2015, Annals of the American Thoracic Society.
[84] Onofrio Resta,et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. , 2009, Lung cancer.
[85] P. Montuschi. Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications , 2007, Therapeutic advances in respiratory disease.
[86] Yoshihiro Kakeji,et al. Colorectal cancer screening with odour material by canine scent detection , 2011, Gut.
[87] F Levi,et al. European cancer mortality predictions for the year 2018 with focus on colorectal cancer , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[88] David Smith,et al. Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[89] Wolfram Miekisch,et al. Data interpretation in breath biomarker research: pitfalls and directions , 2012, Journal of breath research.
[90] M. Fiegl,et al. Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.
[91] P. Martínez-Lozano,et al. Electrospray ionization of volatiles in breath , 2007 .
[92] Bettina Zelger,et al. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers , 2014, Journal of breath research.
[93] HywelC. Williams,et al. Another sniffer dog for the clinic? , 2001, The Lancet.
[94] Royston Goodacre,et al. Exhaled breath analysis: a review of ‘breath-taking’ methods for off-line analysis , 2017, Metabolomics.
[95] Jörg Ingo Baumbach,et al. Exhaled Breath Analysis for Lung Cancer Detection Using Ion Mobility Spectrometry , 2014, PloS one.
[96] H. Haick,et al. Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials. , 2008, Nano letters.
[97] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[98] P. Panl. The selected ion flow tube (SIFT)?A novel technique for biological monitoring , 1996 .
[99] P. J. Barnes,et al. Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.
[100] Giorgio Pennazza,et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease , 2017, European Respiratory Journal.
[101] G. E. Carpagnano,et al. HPV in exhaled breath condensate of lung cancer patients , 2011, British Journal of Cancer.
[102] Josef Guttmann,et al. CO2-controlled sampling of alveolar gas in mechanically ventilated patients , 2001 .
[103] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[104] Giorgio Pennazza,et al. Electronic Nose Technology in Respiratory Diseases , 2017, Lung.
[105] A. Hansel,et al. On-line monitoring of volatile organic compounds at pptv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS) medical applications, food control and environmental research , 1998 .
[106] G. Gioia,et al. IL-2, TNF-α, and leptin : Local versus systemic concentrations in NSCLC patients , 2006 .
[107] Philipp Lirk,et al. Mass spectrometric profile of exhaled breath—field study by PTR-MS , 2005, Respiratory Physiology & Neurobiology.
[108] F. Pirrone,et al. Canine Scent Detection of Lung Cancer : Preliminary Results , 2016 .
[109] B. Buszewski,et al. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[110] David Smith,et al. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma , 2015, Annals of surgery.
[111] Tarek Mekhail,et al. Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[112] Alphus D. Wilson,et al. Applications and Advances in Electronic-Nose Technologies , 2009, Sensors.
[113] Aamir Ahmad,et al. Lung Cancer and Personalized Medicine , 2016, Advances in Experimental Medicine and Biology.
[114] Zhen Zhou,et al. Direct human breath analysis by secondary nano-electrospray ionization ultrahigh-resolution mass spectrometry: Importance of high mass resolution and mass accuracy. , 2017, Rapid communications in mass spectrometry : RCM.
[115] M. Phillips,et al. Prediction of breast cancer risk with volatile biomarkers in breath , 2018, Breast Cancer Research and Treatment.
[116] Ping Wang,et al. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. , 2012, Cancer biomarkers : section A of Disease markers.